Urology Devices Market Share

North American Market Forecast

North America industry is set to account for largest revenue share of 37% by 2037 backed by the increased number of patients diagnosed with kidney diseases, growing incidences of other urologic conditions, and favorable reimbursement policies in the region As per the Centers for Disease Control and Prevention (CDC), by 2023, approximately 37 million adults in the United States are expected to have chronic kidney disease, with the vast majority remaining undiagnosed. Also, the presence of a strong healthcare system and major key players in the region are considered to be other growth factors for the market. Moreover, the increased utilization rate of single-use cystoscopes for treatment purposes, along with the rise in the development of technologically advanced urology devices by market players, have been anticipated to fuel market growth in this region in the upcoming years. In addition, there has been increasing adoption of advanced level devices such as urology laser for the removing stone that are located in the urinary tract, that is expected to drive the market’s growth in the region.